50% off the $29 audit or $99 Fix-It Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. MABT.US just got measured.
4/10 means MABT.US is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Values Leadership Executive Team Board of Directors Login News Contact Contact Us Privacy Working Towards a Brighter Future MABT Acquires XPose Therapeutics Mid-Atlantic BioTherapeutics is thrilled to announce the acquisition of XPose Therapeutics, a transformative milestone that expands our oncology pipeline and accelerates our mission to deliver breakthrough therapies to patients in need.
1
Structured Data
4
Content Structure
5
Entity Clarity
6
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for MABT.US.
Scored by Engagemii on June 24, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/mabt-us
Cite this score: Engagemii (2026). "AEO Score for MABT.US." Retrieved from https://engagemii.com/aeo/brands/mabt-us
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform